Last reviewed · How we verify
Malignant neoplasm of brain
Approved treatments
- Gliadel · Avet Lifesciences
Gliadel works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and grow. - Carmustin · University Hospital Freiburg
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant neoplasm of brain patent landscape — cliff calendar, originator estates, attackable patents
- Malignant neoplasm of brain treatment landscape brief
- Malignant neoplasm of brain treatment updates RSS
Frequently asked questions about Malignant neoplasm of brain
What drugs treat Malignant neoplasm of brain?
Tracked treatments include Gliadel, Carmustin.
What is the treatment for Malignant neoplasm of brain?
Standard treatment for Malignant neoplasm of brain includes Gliadel, Carmustin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Malignant neoplasm of brain patent cliff · Malignant neoplasm of brain CI report
- Treatment: Gliadel · Avet Lifesciences
- Treatment: Carmustin · University Hospital Freiburg
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing